Kewaunee Scientific reports Q1 EPS $1.04 vs. 74c last year

Reports Q1 revenue $71.1M vs. $48.3M last year. “Our Domestic and International segments delivered solid financial performance in Q1 despite challenging market conditions as a result of uncertain government policy, evolving tariff structures and broader geopolitical upheaval,” said CEO Thomas Hull III. “While our overall backlog remains near historically high levels, we are experiencing volatility in project delivery timelines that we expect will cause uneven performance by quarter for the balance of fiscal year 2026, likely starting in the second quarter. This is a reality of both the uncertainty in the market, and the nature of construction-related manufacturing, where project timing often shifts, causing peaks and valleys in production schedules. Kewaunee is focused on growth, both organically and inorganically, and is committed to making strategic investments in the people, processes, and technology that will support and enable this growth in a sustainable manner. These important investments are accounted for in the Corporate segment and, while some of the costs are expected to be non-recurring in nature, many of them will not be. Though this will place pressure on earnings growth in the near term, we believe it will position Kewaunee for rapid and sustained growth in the future, allowing us to gain leverage on these investments over the long term.”